老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Theravance Biopharma Inc.

11.35
+0.10000.89%
盘后：11.350.00000.00%16:04 EDT
成交量：15.32万
成交额：173.40万
市值：5.68亿
市盈率：-9.57
高：11.41
开：11.22
低：11.17
收：11.25
数据加载中...
总览公司新闻公告
2020/09/14

重要事件披露

8-K - Current report
2020/08/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/06

重要事件披露

8-K - Current report
2020/07/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/06

重要事件披露

8-K - Current report
2020/06/25

重要事件披露

8-K - Current report
2020/06/23

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/06/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/17

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/10

重要事件披露

8-K - Current report
2020/05/08

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/05/06

重要事件披露

Current report, items 2.02 and 9.01
2020/04/29

重要事件披露

8-K - Current report
2020/04/09

重要事件披露

Current report, items 8.01 and 9.01
2020/03/09

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/03/04

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/03/03

员工持股计划

Securities to be offered to employees in employee benefit plans
2020/02/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/02/27

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
更多